We have recently shown that oxytocin inhibits cell proliferation when the vast majority of oxytocin receptors are excluded from caveolin-1-enriched microdomains, and that, on the contrary, it has a mitogenic effect when the receptors are targeted to these plasma membrane domains. In this study, we investigated whether the receptors located inside and outside caveolar microdomains initiate different signalling pathways and how this may lead to opposite effects on cell proliferation. Our data indicate that, depending on their localization, oxytocin receptors transactivate EGFR and activate ERK1/2 using different signalling intermediates. The final outcome is a different temporal pattern of EGFR and ERK1/2 phosphorylation, which is more persistent when the receptors are located outside caveolar microdomains and inhibit cell growth, and very transient when they are located in caveolar microdomains and stimulate cell growth. Finally, only the activation of receptors located outside caveolar microdomains correlates with the activation of the cell cycle inhibitor p21 WAF1/CIP1 , thus suggesting that the antiproliferative OTR effects may, in this case, be achieved by a sustained activation of EGFR and MAPK leading to the induction of this cell cycle regulator.
Introduction
Caveolae are flask-shaped, uncoated plasma membrane invaginations that are present in many cell types. It has been found that a number of membrane receptors, signalling molecules and membrane transporters localize to caveolae, and this has led to the formulation of the 'caveolae signalling hypothesis' suggesting that they may act as centres for regulating cell signalling activity (Anderson, 1993; Janes et al., 2000; Simons and Toomre, 2000; Galbiati et al., 2001) . It can also be hypothesized that disruption of the plasma membrane environment in which signalling cascades take place may lead to chaotic signalling and, in the case of growthcontrol signals, contribute to abnormal cell proliferation and neoplastic transformation.
OTRs were originally thought to be present only in the uterus, mammary gland and central nervous system, but they have recently been found in a number of other tissues and organs, as well as in tumoral cells of various origin (breast and endometrial carcinomas, neuroblastomas, glioblastomas, Kaposi sarcomas, small-cell lung carcinomas) (Bussolati and Cassoni, 2001) . Functional OTRs have also been described in osteoblasts (Copland et al., 1999) and endothelial cells (Thibonnier et al., 1999) , and it has recently been suggested that they play a specific role in the differentiation of cardiomyocytes (Paquin et al., 2002) and myoblasts (Breton et al., 2002) . Interestingly, although only one OTR-encoding gene has been cloned and found to be expressed in various tissues and cell lines, OT stimulates, inhibits or has no effect on cell proliferation, depending on the cell system (Bussolati and Cassoni, 2001) . These different effects seem to be mediated by different signalling pathways, including an increase in calcium, the formation of cAMP and the activation of MAP kinases. However, it is difficult to identify the factors determining the different outcomes of OTR activation because of the extreme variability in signalling intermediates in different cell lines and tissues (G-protein types and levels, adenylate cyclases and PKC isoforms, adhesion molecules, etc.). Recent evidence indicates that the transient and/or partial localization of G-proteincoupled receptors in caveolar domains may regulate specific signalling responses (Dessy et al., 2000; Rybin et al., 2000; Ushio-Fukai et al., 2001) . In line with this view, we have previously found that caveolae represent a membrane compartment in which the human OTR may accomplish specific signalling tasks related to the control of cell proliferation. In MDCK cells, where the vast majority of stably transfected OTRs are excluded from caveolin-rich domains, OT inhibits cell proliferation. However, when OTRs are targeted to caveolae after being fused to caveolin-2, the hormone has a strong mitogenic effect, indicating that the fraction of OTRs compartmentalized in caveolae domains may influence the proliferative/antiproliferative effects of OT (Guzzi et al., 2002) .
We postulated that, in order to achieve these opposite effects on cell growth, the human OTR may activate different transduction pathways depending on its localization in different membrane microdomains. In order to test this hypothesis, HEK293 cells were transfected with wild type (WT) OTRs (mainly excluded from caveolar microdomains) or WT OTRs targeted to caveolin-1-enriched microdomains as a result of their fusion to caveolin-2. Our results indicate that, in order to elicit opposite effects on cell growth, the human OTRs localized inside or outside caveolin-enriched microdomains couple to different G-proteins and lead to different temporal patterns of MAPK/EGFR activation.
Results
OTRs located inside or outside caveolin-1-enriched microdomains activate different signalling pathways leading to the inhibition or stimulation of cell growth
In order to identify the signalling pathways initiated by the OTRs inside or outside caveolar microdomains, HEK293 cells were transfected with the WT OTR-GFP or the WT OTR-GFP fused to the full-length sequence of caveolin-2 (OTR-GFP-cav2). One clone for each construct was selected on the basis of the clear fluorescent staining of the cell plasma membrane and the presence of caveolar structures (Figure 1a, b) , and saturation binding analysis demonstrated that these two clones expressed similar amounts of high-affinity binding sites for radiolabelled oxytocin (K d ¼ 2574.2 nm for the WT OTR-GFP and 672.1 nm for OTR-GFP-cav2, B max ¼ 8087150 and 19517232 fmol/mg protein for the WT OTR-GFP and OTR-GFP-cav2, respectively). Agonist treatment of HEK293 cells expressing WT OTR-GFP significantly inhibited cell growth at every time point (Figure 1c ), but significantly stimulated the proliferation of cells expressing OTR-GFP-cav2 even at the earliest time of treatment (24 h) (Figure 1d ). Doseresponse curves of the OT-induced effects on cell proliferation showed very similar values for the inhibitory effect on WT OTR-GFP (IC 50 ¼ 22.074.3 and 1573.3 nm in two independent assays) and the OTelicited stimulatory effect on OTR-GFP-cav2 (EC 50 ¼ 35.675.5 and 2878.6 nm in two independent assays). As previously found for MDCK cells, only the OTR-GFP-cav2 receptor was targeted to caveolinenriched fractions, as determined by flotation sucrose gradients after cell solubilization in cold 1% Triton X-100 (not shown).
To check the ability of various pharmacological inhibitors to block OTR-mediated proliferative or antiproliferative effects, the OT-induced effects on cell proliferation were evaluated by treating the cells with concentrations of inhibitors leading to a less than 30% reduction in cell viability.
As human OTRs couple with both Gaq and Gai, we first analysed blockers of these effector pathways. As shown in Figure 2 , the treatments with pertussis toxin (PTX) (a specific Gai inhibitor) and U73122 (a PLC inhibitor) were equally effective in abolishing the antiproliferative effect mediated by WT OTR-GFP, but were unable to block the proliferative effect mediated by OTR-GFP-cav2. The specificity of U73122 was checked using the inactive compound U73343, which did not show any activity in the cells expressing WT OTR-GFP or those expressing OTR-GFP-cav2.
It is known that human OTRs activate PLA2 and prostaglandin (PG) release by means of PLC activation (Moore et al., 1988) . In order to check whether this pathway plays a role in the proliferative or antiproliferative effects, we blocked PG synthesis with indomethacin. Under these conditions, neither of the OTR-mediated effects were affected, thus indicating that PG production is not involved in mediating the OTR-induced responses on cell growth in our system. ERK1/2 activation and EGFR transactivation were involved in both the anti-proliferative and the prolif- À7 m for 24, 48 and 72 h, and the cell proliferation was determined using an MTS-based assay. The data are representative of three independent experiments each performed in sestuplicate Oxytoxcin receptor signalling in lipid rafts V Rimoldi et al erative responses, as indicated by the efficacy in abolishing the OTR-mediated effects of both PD98059 (a MEK inhibitor) and AG1478 (an inhibitor of EGFR kinase activity). EGFR transactivation was achieved in both cases by means of the participation of a specific metalloproteinase, as indicated by the CRM197 blockade. However, although the PP2 c-Src inhibitor completely blocked the inhibition of cell growth mediated by WT OTR-GFP, it had no effect on OTR-GFP-cav2-mediated cell proliferation.
Finally, wortmannin and rapamycin, which, respectively, inhibit the PI3 K and AKT pathways, had no effect on OTR-GFP-cav2-mediated cell proliferation, whereas PI3 K was involved in mediating the WT OTR-GFP inhibition of cell growth.
In conclusion, our data indicate that the inhibition of cell growth by stimulation of OTRs excluded from caveolin-enriched microdomains depends on EGFR phosphorylation and ERK1/2 activation by means of a Gai-, PLC-, c-Src-and PI3K-dependent pathway, the stimulation of cell growth by OTRs localized in such microdomains involves ERK1/2 activation and EGFR transactivation by means of a Gai-, PCL-, c-Src-and PI3K-independent pathway.
Activation of WT OTR-GFP and OTR-GFP-cav2 receptors leads to a temporal difference in MAPK phosphorylation
As ERK1/2 activation proved to be crucial in mediating both the inhibition and stimulation of cell growth, we looked for spatio-temporal differences in ERK1/2 activation patterns that may explain these opposite outcomes (Marshall, 1995; Roovers and Assoian, 2000; Volmat and Pouyssegur, 2001 ). Our results in MDCK cells indicated that ERK1/2 remain phosphorylated for a longer time after stimulation of WT OTR-GFP than after stimulation of OTR-GFP-cav2. As shown in Figure 3 , after 3 h of agonist stimulation, there was a strong doublet corresponding to phospho-ERK1/2 in the cells expressing WT OTR-GFP, whereas the levels in the cells expressing OTR-GFP-cav2 had returned to baseline values. In order to confirm these results, we used a longer period for the experiments involving HEK293 cells. As shown in Figure 3 , phospho-ERK1/2 remained activated in the cells expressing WT OTR-GFP for up to 12 h, whereas stimulation of the OTR-GFP-cav2 receptor led to a very transient activation of ERK1/2, which peaked after 5 min and then declined.
We then analysed whether phospho-ERK1/2 translocates to the nucleus in WT OTR-GFP-and OTR-GFP-cav2-expressing cells. As shown in Figure 4 , phospho-ERK1/2 was detected in the nuclear fractions prepared from both the cell types.
Transient versus sustained activation of EGFR at tyrosine 1068, and activation of the cell cycle inhibitor p21
As EGFR was also involved in mediating both the proliferative and antiproliferative responses, we looked for temporal differences in its phosphorylation profile using an antibody recognizing the EGFR phosphorylated at tyrosine 1068, the direct binding site for the SH2 domain of Grb2 whose recruitment leads to Ras activation. As shown in Figure 5a , stimulation of WT OTR-GFP led to sustained EGFR phosphorylation at tyrosine 1068, whereas only transient activation was observed at the same site after stimulating OTR-GFPcav2.
Finally, we investigated whether the sustained EGFR/ MAPK activation by WT OTR-GFP correlates with the induction of the cell cycle inhibitor p21
, as recently reviewed in Roovers and Assoian (2000) . As shown in Figure 5b , Western blot analyses showed that Figure 2 Signalling pathways involved in OT-induced growth regulation. WT OTR-GFP and OTR-GFP-cav2 cells were pretreated for 4 h with 150 ng/ml PTX, or for 30 min with 1 mm U73122 (a PLC inhibitor), 1 mm U73343 (an inactive compound related to U73122), 10 mm indomethacin (a PLA 2 inhibitor), 250 nm wortmannin (a PI3K inhibitor), 3 mm AG1478 (an EGFR inhibitor), 5 mm PD98059 (a MEK inhibitor), 100 nm rapamycin or for 15 min with 1 mm PP2 (a c-Src inhibitor), or for 45 min with 10 mg/ml CRM197 (an inhibitor of the metalloproteinase involved in the release of proHB-EGF), and were then stimulated with OT at a final concentration of 10 À7 m. For each drug, the OT-induced variations in cell number were determined with respect to control cells maintained in presence of the drug at the indicated concentration in at least four independent experiments each performed in sestuplicate; the results were analysed by unpaired t-test (*Po0.05; **Po0.01; ***Po0.001). nd: not determined Oxytoxcin receptor signalling in lipid rafts V Rimoldi et al the level of p21 WAF1/CIP1 protein increases upon the stimulation of WT OTR-GFP as early as 3 h after agonist application, whereas no change in its overall expression was observed upon the stimulation of OTR-GFP-cav2. These data suggest that the more persistent EGFR and MAPK phosphorylation observed after the activation of OTRs located outside caveolin-1-enriched microdomains may lead to inhibition of cell growth by activating p21 WAF1/CIP1
. Discussion GPCR-mediated effects on cell growth and differentiation are ultimately produced by the activation of MAPK by means of various mechanisms, including classical second messengers, receptor tyrosine kinases transactivation and the recruitment of scaffolding proteins during endocytosis (Gutkind, 1998; Liebmann, 2001; Pierce et al., 2001) , but understanding how this complex network of signalling molecules is orchestrated is still a daunting task. À7 m for the indicated periods of time. After cell fractionation, the cytoplasmic and nuclear proteins were resolved by means of 11% SDS-PAGE. Western blotting was performed with a polyclonal antiphospho-ERK antibody. Anti-SP3 (a nuclear transcription factor) and antib-tubulin were used as markers of nuclear and cytoplasmic proteins, respectively. The blots are representative of two independent experiments Figure 5 Time course of EGFR and p21 WAF1/CIP1 activation in OTtreated cells. The cells were treated with OT 10 À7 m for various periods of time. The cells were lysed and 30 mg of proteins were resolved by means of SDS-PAGE. The blots are representative of two independent experiments. (a) EGFR phosphorylation was detected using a phosphospecific antibody directed against tyrosine 1068; the position of the specific band recognized by the antibody is indicated by an arrow. Total EGFR was detected using a polyclonal antibody. (b) p21 WAF1/CIP1 induction was detected using a specific polyclonal antibody. (c) After the acquisition of the audioradiogram shown in (b), the band densities were quantitated using the NIH Image Program ver 1.61
Oxytoxcin receptor signalling in lipid rafts V Rimoldi et al It has been postulated that plasma membrane microdomains play an important role in organizing and regulating a number of signalling components (Anderson, 1993; Okamoto et al., 1998; Simons and Toomre, 2000) and, in line with this hypothesis, we have found that stimulation of the oxytocin receptors located in different microdomains of the plasma membrane leads to opposite effects on cell proliferation (Guzzi et al., 2002) .
In order to identify the signalling pathways initiated by OTRs inside and outside caveolin-enriched microdomains, we now produced stably transfected HEK293 cells expressing the WT OTR-GFP and OTR-GFP-cav2 proteins, a strategy previously used in MDCK cells (Guzzi et al., 2002) . The HEK293 cell system, which has been widely used to clarify the pharmacological properties of a number of GPCRs, also allowed us to demonstrate that the proliferative/antiproliferative effects previously observed in MDCK cells are not because of the cell type, but are intrinsic properties of the human OTRs targeted to different plasma membrane domains.
We first investigated whether the OTRs located in different plasma membrane compartments activate different second messenger systems. Our results indicate that the stimulation of WT OTR-GFP and OTR-GFPcav2 leads to the activation of EGFR and ERK1/2 via different receptor coupling to Ga subunits. The human OTR is a typical GPCR that is coupled to both Gaq and Gai. The role played by Gaq activation after OTR stimulation is certainly the best known: the stimulation of OTRs in the uterus (in which OTR expression specifically increases at the end of gestation) induces an increase in intracellular Ca þ þ leading to contraction (Sanborn, 2001) . The physiological effects of Gai coupling are less understood, but it has been shown that part of the OTR response in the uterus is PTXsensitive (Phaneuf et al., 1993) , and that OTRs and Gai coimmunoprecipitate (Strakova and Soloff, 1997) . We found that OTR coupling to Gai is especially important in mediating the inhibition of cell growth because the inhibitory effect mediated by WT OTR-GFP stimulation was completely abolished by PTX treatment. Only a few examples of peptide GPCRs inhibiting cell growth have so far been identified (Liebmann, 2001 ), all of which (including the somatostatin receptor subtypes SST1, SST2, SST3 and SST5 and the AT2 angiotensin receptor) are coupled to Gai. We also found that the inhibition of cell growth was abolished after treatment with the U73122 PLC inhibitor, possibly as a result of PLC activation by the bg complexes released by Gai. bg complexes are also probably involved in mediating c-Src and PI3 K activation, although it is possible that c-Src is directly activated by Gai (Ma et al., 2000) . PLC, c-Src and PI3 K may then lead to MAPK activation by means of Ras-dependent or Ras-independent pathways. PTX pretreatment did not block the mitogenic effect mediated by the OTRs located in caveolin-enriched domains, which thus probably takes place as a result of Gaq coupling; however, we cannot offer any definite proof because we did not use a specific Gaq blocker.
After OTR-GFP-cav2 activation, the bg complexes released by Gaq may play a major signalling role, since PLC, c-Src and PI3 K do not seem to be involved. It is interesting to note that Gaq has been found to be particularly enriched in caveolin-enriched domains (Oh and Schnitzer, 2001) , which suggests the possibility of preferential receptor coupling to this Ga subunit in these domains.
Regardless of their localization in caveolin-1-enriched microdomains, stimulation of OTRs is associated with EGFR transactivation and activation of ERK1/2. However, OTR stimulation inside or outside caveolar microdomains led to different EGFR/ERK1/2 phosphorylation kinetic profiles: stimulation of the receptors located outside caveolar microdomains led to sustained activation, whereas stimulation of the receptors located inside caveolar microdomains led to a more transient phosphorylation. This difference may result from the different activation pathways used by the OTRs inside/outside caveolar microdomains to transactivate EGFRs. It is interesting to note that also in completely different cell system, the Hep3B hepatoma cell line, EGF and compound 5 (a PTPase) stimulate or inhibit cell growth by means of transient or sustained EGFR and ERK1/2 activation (Adachi et al., 2002) .
As extensively discussed elsewhere, EGFRs play a key role in integrating the signalling events leading to cell growth regulation (Carpenter, 1999; Prenzel et al., 2001) , and EGFR transactivation leading to ERK1/2 activation has been recently demonstrated in a number of GPCRs (Gschwind et al., 2001) . ERK1/2 are key cell proliferation regulators, and their activation can lead to opposite biological effects (proliferation/inhibition of cell growth; differentiation/dedifferentiation) depending on their activation kinetics and subcellular distribution, as originally postulated by Marshall (Marshall, 1995) . It could thus be hypothesized that the activation of OTRs via different signalling pathways leads not only to a different temporal pattern of ERK1/2 activation, but also to their different cytoplasmic/nuclear localization, as shown for example for the PAR2 receptor (DeFea et al., 2000) . However, our data indicate that OTR stimulation in HEK293 cells led to nuclear translocation of ERK1/2 regardless of the signalling pathway originally involved in their activation.
The signalling events leading to cell proliferation in response to EGFR stimulation have been extensively described, but the EGFR stimulation leading to the inhibition of cell growth has not yet been fully clarified. In a number of cell lines, EGF-induced inhibition of cell growth is associated with the overexpression of the receptor itself and the activation of the cell cycle inhibitor p21 WAF1/CIP1 (Filmus et al., 1985; Fan et al., 1995; Jakus and Yeudall, 1996; Xie et al., 1997; Johannessen et al., 1999) , or with the induction of STAT1 (Bromberg et al., 1998) . For example, it has recently been shown that EGFR activation in MDA-468 breast cancer cells inhibits cell growth by means of an increased transcription of the p21 WAF1/CIPl gene and the stabilization of its mRNA (Giles et al., 2002) . In line with these findings, we found that the inhibition of cell proliferation by means of WT OTR-GFP stimulation correlates with the induction of p21 WAF1/CIP1 , thus suggesting that the sustained EGFR/MAPK stimulation switches on this cell cycle regulator. It has been shown that the SST1 somatostatin receptor, whose stimulation also inhibits cell growth, also induces p21 WAF1/CIP1 (Florio et al., 1999) , and it would be interesting to investigate if EGFR transactivation and sustained ERK1/2 phosphorylation are also involved in somatostatin-mediated cell growth inhibition. As EGFR partitioning in caveolae depends on their functional status (Mineo et al., 1999) and EGFR trafficking is essential for their activity (Carpenter, 2000) , it would also be very interesting to investigate the functional status of the EGFRs located in caveolar microdomains after WT OTR-GFP and OTR-GFP-cav2 activation.
In conclusion, depending on whether they are located inside or outside caveolar microdomains, the human OTR couples to different G proteins and leads to different temporal patterns of EGFR and ERK1/2 activation resulting in opposite effects on cell growth, which (in addition to other still not unravelled pathways) involve the induction of the specific cell cycle regulator p21
. These results represent a working hypothesis for investigating how OTR activation in normal and cancer cells of different origin may lead to opposed effects on cell growth.
Materials and methods

Peptides and reagents
OT, PTX, U73122, U73343, wortmannin, CRM197, and PD98059 were obtained from Sigma. AG1478 and indomethacin were a gift of Professor E Rovati (Milan, Italy), PP2 was a gift of Professor A. Graziani (Novara, Italy). The origins of the primary antibodies were as follows: polyclonal anti-SP3 (#sc-644) and anti-p21 (#sc-397) from Santa Cruz Biotechnology Inc.; polyclonal anti-b-tubulin (#T5293 clone 2-28-33) from Sigma; polyclonal anti-p42/44 MAPKinase (#9102), antiphospho p42/44 MAPKinase (#9101), antiphospho-EGFR (Tyr1068) (#2234) and anti-EGFR (#2232) from Cell Signalling Technology; peroxidase conjugated secondary antibodies were from Pierce.
Generation of fusion constructs and transfection
The generation of WT OTR-GFP and OTR-GFP-cav2 cDNA has been previously described (Guzzi et al., 2002) . HEK293 cells, obtained from ATTC, were transfected using the Lipofectamine reagent (GibcoBRL); the resistant clones were selected using G418 (1 mg/ml) and collected using cloning rings (Sigma).
Fluorescence and transmission electron microscopy
Cells were grown on glass coverslips precoated with 0.5% gelatin, fixed for 20 min at room temperature (RT) with 4% (w/v) paraformaldehyde and observed under an MRC1024 BioRad confocal microscope. For transmission electron microscopy, the cell pellets were fixed with 2% glutaraldehyde in 0.1 m cacodylate buffer pH 7.4, postfixed with 1% osmium tetroxide in the same buffer for 1 h at RT, washed extensively, dehydrated in ethanol series and then embedded in Epon. Sections of pale-gold, silver interference colour were obtained with a Reichert Ultracut E ultramicrotome, collected on copper grids, counter stained with a saturated aqueous solution of uranyl acetate and Reynold's lead citrate and finally examined with a Philips CM10 transmission electron microscope.
Cell growth assay
Experiments were routinely carried out in the log phase of growth after cells had been seeded in 96-multiwell plates (3/ 4000 cells/well) and allowed to adhere for 24-48 h. Cells were cultured in MEM supplemented with 10% FCS. Cells growth was determined by employing an MTS-based assay (Promega's CellTiter 96 s AQueous One Solution Assay) according to the manufacturer's instructions. All treatments were done in sestuplicate. Set-up with known numbers of cells and a linear correlation between absorbance and cell counts were established up to 20 000 cells. Statistical analysis was carried out by student t-test.
Preparation of cell lysates and Western blot analysis
After 1 h starvation in serum-free medium, cells were stimulated with OT at the final concentration of 10 À7 m for the indicated periods of time. Cells were then washed once in ice-cold PBS and lysed in 50 mm Tris-HCl pH 6.8, 2% SDS preheated at 1001C. After 4-5 cycles of freezing in dry-ice and boiling for 2 min, aliquots of the lysates were assayed for protein content using the BCA protein assay (Pierce) . Cellular proteins (30 mg) were resolved by Laemmli SDS-PAGE system using 6 or 11% (w/v) acrylamide gels (Laemmli, 1970) and then blotted onto 0.45 mm pore size nitrocellulose membranes (Costar). Blots were incubated overnight at 41C in TBS (20 mm Tris-HCl, pH 7.4, 150 mm NaCl), containing 5% powdered skim milk. The membranes were then incubated for 2 h with primary antibodies diluted in TBS/milk and for 2 h with horseradish peroxidase-conjugated goat anti-mouse/rabbit IgG (Pierce) . When antiphospho antibodies were used, blocking was performed in 5% BSA/0.2% (v/v) Tween 20 and incubation was performed O/N in TBS/BSA. Proteins were detected using the SuperSignal s chemiluminescent substrate (Pierce) . For quantification, unsaturated bands were acquired by means of an Arcus II Scanner (Agfa-Gevaert, Germany) and analysed with the NIH Image program ver 1.61 (National Technical Information Service, Springfield, USA).
Preparation of cytosolic and nuclear extracts
Cells were stimulated as described above. After a quick wash in ice-cold PBS, cells were gently collected, counted, centrifuged, resuspended at a final concentration of 5 Â 10 7 cells/ml in 10 mm HEPES pH 7.9, 1.5 mm MgCl 2 , 10 mm KCl, 0.05% NP40 supplemented with proteases and phospathases inhibitors (Sigma) by vigorous pipetting and allowed to swell and lyse on ice for 10 min. After centrifugation at 200 g for 10 min at 41C, supernatants were saved as the cytosolic fractions. The pellets, resuspended in 20 mm HEPES pH 7.9, 1.5 mm MgCl 2 , 0.42 m NaCl, 0.2 mm EDTA, 25% glycerol supplemented with proteases and phosphatase inhibitors (Sigma), were then briefly sonicated and collected as the nuclear fractions. An equal volume of each fraction was loaded on acrylamide gels and analysed by Western blotting. The purity of the cytosolic and nuclear fractions was checked by analysing the presence of b-tubulin (a cytosolic protein) and SP3 (a nuclear transcription factor) with specific antibodies.
